UPC_APP_19959/2024

The Paris Central Division exercised its discretion to admit Edwards Lifesciences' subsequent request to amend patent EP 3 646 825 after the written procedure had closed, provided that Meril Italy was granted additional time to submit a defence to the new amendment, holding that such admission does not prejudice the opposing party's right of defence.